Skip to content
RDL Network logo
The efficacy of Drotrecogin alfa (activated) during a global, single-arm, open-label trial in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS — Jean Louis Vincent (2004) | RDL Network